Screener
BioMarin Pharmaceuticals BMRN Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $11.06B.
The source filing: BioMarin Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:14 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001048477-26-000016
FAQ
- What is BioMarin Pharmaceuticals's market capitalization?
- BioMarin Pharmaceuticals (BMRN) reported market capitalization of $11.06B in Q2 2026.
- How has BioMarin Pharmaceuticals's market capitalization changed year-over-year?
- BioMarin Pharmaceuticals's market capitalization increased by 5.4% year-over-year, from $10.49B to $11.06B.
- What is the long-term trend for BioMarin Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's market capitalization has grown at a -6.6% compound annual growth rate (CAGR), from $16.1B to $11.42B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about BioMarin Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude